DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Silmitasertib
Silmitasertib
Targeting Protein Kinase CK2 and CDK4/6 Pathways with a Multi-Kinase Inhibitor ON108110 Suppresses Pro-Survival Signaling and Gr
Tanibirumab (CUI C3490677) Add to Cart
WO 2017/173206 Al 5 October 2017 (05.10.2017) P O P C T
Abstract Book
Targeting Stat3 and Kinases in Lymphoid Malignancies
Development of Rational Combination Therapy with Parp Inhibitors and Kinase Inhibitors in Tnbc
Inflammatory Discovery in COVID-19
A SARS-Cov-2 Protein Interaction Map Reveals Targets for Drug Repurposing
Stembook 2018.Pdf
Inhibitors & Agonists Compound Screening Libraries
2018 Medicines in Development for Cancer
The Network Edge Volume 13: Fall, 2016
CK2 Inhibition with Silmitasertib Promotes Methuosis-Like Cell Death
Peer Reviewed Publications for 2020 (Pdf)
Casein Kinase 2 Controls the Survival of Normal Thymic and Leukemic Γδ T Cells Via Promotion of AKT Signaling
Cdc-Like Kinases (Clks): Biology, Chemical Probes, and Therapeutic Potential
An Exon Skipping Screen Identifies Antitumor Drugs That Are Potent Modulators of Pre-Mrna Splicing, Suggesting New Therapeutic A
New Approaches in Targeted Therapy for Medulloblastoma in Children HENRIETTA MAIER, TINA DALIANIS and OURANIA N
Top View
The Landscape of Human Cancer Proteins Targeted by SARS-Cov-2
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Phosphoproteomics Reveals HMGA1, a CK2 Substrate, As a Drug-Resistant Target in Non-Small Cell Lung Cancer
Simultaneous Inhibition of Protein Kinase CK2 and Dihydrofolate
Abemaciclib, a Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas
Proximity Labeling-Assisted Identification of Endogenous Kinase Substrates
Cellular Features Predicting Susceptibility to Ferroptosis: Insights from Cancer Cell-Line Profiling
Riport Letöltése
2020 Medicines in Development ꟷ Cancer
UC Berkeley UC Berkeley Electronic Theses and Dissertations
International Nonproprietary Names for Pharmaceutical Substances (INN)
Survey of Ex Vivo Drug Combination Effects in Chronic Lymphocytic Leukemia Reveals Synergistic Drug Effects and Genetic Dependencies
WHO Drug Information Vol. 24, No. 2, 2010 World Health Organization
A Drug-Screening Platform Based on Organotypic Cultures Identifies Vulnerabilities to Prevent Local Relapse and Treat Established Brain Metastasis
6492.TT Senhwa Announces Multiple IND Application Submissions to U.S
DYRK1A Inhibitors
TABLE S2 Manic El Al.Xlsx
Chemical Systems Biology Studies of Triple Negative Breast Cancer Cell Lines Recent Publications in This Series